For CHEK2, a two-fold association has been reported for patients with familial pancreatic cancer in a recent study from Poland, but the association was not seen in unselected PDAC patients or individuals in familial pancreatic cancer families who did not have cancer [32]. This evidence concerns the gene CHEK2 and pancreatic neoplasm.